Jubilant Bhartia Group to acquire 40% stake in Hindustan Coca-Cola Beverages for ₹12,500 crore

The Bhartia family, owners of Jubilant Bhartia Group, is set to acquire a 40% stake in Hindustan Coca-Cola Beverages (HCCB), Coca-Cola India’s exclusive bottling arm, for ₹12,500 crore. This marks the group’s largest acquisition to date, as reported by The Economic Times.

Key Highlights of the Deal:

Advertisement

  1. Acquisition Details:
    • The Bhartia family will acquire the stake through a special purpose vehicle (SPV) exclusively financed by Goldman Sachs.
    • The family will contribute approximately ₹5,000 crore of their own funds to avoid over-leveraging.
  2. Strategic Significance:
    • This acquisition aligns with Coca-Cola India’s asset-light strategy, which mirrors PepsiCo’s approach of offloading bottling operations to enhance value and focus on core operations.
    • Industry experts believe this move could eventually pave the way for an HCCB IPO to establish its valuation.
  3. HCCB’s Financial Performance:
    • HCCB posted ₹14,021 crore in revenue for FY24, a 9.2% increase YoY, with a 247% surge in net profit.
    • It plans to invest $1.5 billion over the next five years to expand its bottling capacities and build new facilities in Gujarat and Madhya Pradesh.
  4. Coca-Cola India’s Market Outlook:
    • India is Coca-Cola’s fifth-largest market by volume, with significant growth potential due to its low per capita consumption of packaged soft drinks.
    • This acquisition positions HCCB to tap into the expanding demand in the Indian market.
  5. Jubilant Bhartia Group Background:
    • The Bhartia family, also promoters of Jubilant Foodworks Ltd (JFL), holds exclusive franchise rights for Domino’s Pizza in India. This acquisition diversifies their portfolio into the beverage segment.

Industry Context:

Coca-Cola India’s asset-light model reflects a strategy seen earlier with PepsiCo, which transferred its bottling operations to Varun Beverages, leading to significant valuation gains for the latter. A similar trajectory is expected for HCCB post-acquisition.